Search

everythinglearnresearchcommunity

for

Search:↓

Neurosteroids may help treat disorders with too much dopamine activity.

Neurosteroids in the brain can increase or decrease seizure risk in mice.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Clozapine levels in hair reflect dosage and bind more to pigmented hair.

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Betamethasone is more effective long-term for alopecia areata than hydroxychloroquine.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Triamcinolone acetonide helps scalp grafts grow hair successfully.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.